AR101673A1 - Composición para el tratamiento de neuropatías y del dolor neuropático - Google Patents

Composición para el tratamiento de neuropatías y del dolor neuropático

Info

Publication number
AR101673A1
AR101673A1 ARP150102653A ARP150102653A AR101673A1 AR 101673 A1 AR101673 A1 AR 101673A1 AR P150102653 A ARP150102653 A AR P150102653A AR P150102653 A ARP150102653 A AR P150102653A AR 101673 A1 AR101673 A1 AR 101673A1
Authority
AR
Argentina
Prior art keywords
vitamin
neuropathies
treatment
neuropathic pain
composition
Prior art date
Application number
ARP150102653A
Other languages
English (en)
Inventor
Paola Petrelli Rita
Martina Alberto
Lusenti Emanuele
Di Vincenzo Carmine
Bijno Domenico
Original Assignee
Kolinpharma S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kolinpharma S P A filed Critical Kolinpharma S P A
Publication of AR101673A1 publication Critical patent/AR101673A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composición para el tratamiento de neuropatías y/o del dolor neuropático. Composición farmacéutica o integrador alimenticio para el tratamiento de neuropatías y/o del dolor neuropático que comprende, como principios activos, la combinación de curcumina, N-acetil-L-carnitina y ácido a-lipoico. Reivindicación 9: Composición farmacéutica o integrador alimenticio según una cualquier de las reivindicaciones 1 a 8, que comprende además una o más vitaminas seleccionadas en el grupo que consiste en vitamina C, vitamina E, vitamina B1, vitamina B2, vitamina B6 y vitamina B12.
ARP150102653A 2014-08-19 2015-08-18 Composición para el tratamiento de neuropatías y del dolor neuropático AR101673A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITTO20140670 2014-08-19

Publications (1)

Publication Number Publication Date
AR101673A1 true AR101673A1 (es) 2017-01-04

Family

ID=51753396

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150102653A AR101673A1 (es) 2014-08-19 2015-08-18 Composición para el tratamiento de neuropatías y del dolor neuropático

Country Status (9)

Country Link
US (2) US9980940B2 (es)
EP (1) EP3182965B1 (es)
AR (1) AR101673A1 (es)
ES (1) ES2735374T3 (es)
IL (1) IL250594B (es)
PL (1) PL3182965T3 (es)
TR (1) TR201909773T4 (es)
UY (1) UY36273A (es)
WO (1) WO2016027224A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3277273B1 (en) * 2015-03-31 2020-02-26 Kolinpharma S.p.A. A composition for the treatment of neuropathies and/or neuropathic pain
IT201700111261A1 (it) * 2017-10-04 2019-04-04 Neilos S R L Composizione per il trattamento delle neuropatie metaboliche e meccaniche
WO2023086113A1 (en) * 2021-11-11 2023-05-19 Muhammed Majeed Compositions for the management of demyelinating disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005032478A2 (en) 2003-10-01 2005-04-14 Yasoo Health, Inc. Treatment for diabetic microvascular and macrovascular complications
US8247435B2 (en) * 2009-02-19 2012-08-21 Thornthwaite Jerry T Formulations for treating human and animal diseases

Also Published As

Publication number Publication date
US20180243262A1 (en) 2018-08-30
UY36273A (es) 2016-04-01
WO2016027224A1 (en) 2016-02-25
EP3182965A1 (en) 2017-06-28
TR201909773T4 (tr) 2019-07-22
ES2735374T3 (es) 2019-12-18
US20170224656A1 (en) 2017-08-10
PL3182965T3 (pl) 2019-11-29
US9980940B2 (en) 2018-05-29
EP3182965B1 (en) 2019-04-17
IL250594B (en) 2019-09-26
IL250594A0 (en) 2017-04-30

Similar Documents

Publication Publication Date Title
CL2018000706A1 (es) Derivados de pirazolopirimidina como inhibidores btk para el tratamiento del cancer.
BR112018003745A2 (pt) composições que compreendem um composto de urolitina
DOP2016000253A (es) Nuevos compuestos
CL2015002677A1 (es) Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevención de enfermedades o condiciones asociadas con la disfunción mitocondrial.
CL2019001194A1 (es) Extracto de una composición herbal como agente antimicrobiano y/o antibiopelícula.
BR112017003346B8 (pt) Derivados de pirazolopiridina, seus usos, e composição farmacêutica
BR112018003780A2 (pt) composições que compreendem um composto de urolitina
MX2017004772A (es) Composiciones y métodos para la administración fisiológica utilizando cannabidiol.
GT201700280A (es) Formulación sólida oral que contiene irinotecán y método de preparación de la misma
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt
CO2018010937A2 (es) Sistemas de formulación para glicolípidos antimicrobianos
BR112017022523A2 (pt) ?formulação para cápsulas de gel, cápsula de gel, e, processo?.
AR101673A1 (es) Composición para el tratamiento de neuropatías y del dolor neuropático
FR3016289B1 (fr) Extrait vegetal comprenant des sucrose-esters en tant que principe actif et son utilisation dans une composition cosmetique, dermatologique ou nutraceutique
CL2017001472A1 (es) Composiciones y métodos que comprenden triglicéridos de cadena media para el tratamiento de la epilepsia.
AR098742A1 (es) Composición alimenticia realzadora de la palatabilidad para alimento para mascotas y método de preparación
CR20190007A (es) Composiciones farmacéuticas sólidas y formas de dosificación que comprenden aceites.
UY36598A (es) Composición para el tratamiento de neuropatías y/o dolor neuropático
ECSP21027009A (es) Derivados de 4-pirazin-2-ilmetil-morfolina y su uso como medicamento
BR112017014295A2 (pt) composição farmacêutica.
MA39009A (fr) Compositions pharmaceutiques comprenant un agent actif
AR105413A1 (es) Composición farmacéutica para el tratamiento de enfermedades gastrointestinales
AR096540A1 (es) Producto regulador de la salubridad en las plantas, procedimiento de obtención y uso del mismo
GT201400115A (es) Combinación farmacéutica antineurítica y composición
ES2656666T3 (es) Alimento para fines médicos especiales o formulación de suplemento alimenticio para tratar trastornos auditivos

Legal Events

Date Code Title Description
FB Suspension of granting procedure